Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.
Ventas, Inc. is an S&P 500 real estate investment trust with a healthcare and senior housing property portfolio in North America and the United Kingdom. News about VTR commonly covers quarterly results, senior housing operating portfolio performance, occupancy and RevPOR trends, net operating income, healthcare real estate investments, dividends and tax treatment of distributions.
Company updates also address investor presentations, earnings calls, capital allocation and portfolio categories that include senior housing communities, outpatient medical buildings, research centers and healthcare facilities.
Ventas, Inc. (NYSE: VTR) will present at the virtual Nareit REITworld 2020 Conference on November 17, 2020, at 9:30 a.m. ET. Written materials will be available on its website from 8 a.m. ET the same day and will be archived for a limited time. Ventas is a leading Real Estate Investment Trust operating in the healthcare sector, with a diversified portfolio of nearly 1,200 properties as of September 30, 2020. The company focuses on producing consistent cash flows and superior returns while partnering with top healthcare providers and organizations.
Ventas, Inc. (NYSE: VTR) reported its third-quarter 2020 results, revealing significant impacts from the COVID-19 pandemic. Net income decreased by 87% to $0.03 per share, while reported Funds from Operations fell 23% to $0.65 per share compared to Q3 2019. Despite challenges, the company noted improvements in its Senior Housing Operating Portfolio with increased move-ins. Ventas also expanded its Research and Innovation segment, acquiring a $1 billion life science portfolio in South San Francisco. The company maintains strong liquidity with $3.2 billion available for future opportunities.
Ventas, Inc. (NYSE: VTR) has partnered with GIC to form a joint venture aimed at advancing four university-based Research & Innovation (R&I) projects, totaling around $930 million in costs. This JV allows Ventas to maintain a majority stake while enhancing its capital sources and liquidity. The projects are approximately 65% pre-leased and are expected to be completed between 2021 and 2023. This partnership signifies strategic growth in Ventas’s third-party capital management, reflecting confidence in the life sciences sector fueled by an aging global population and increasing funding.
Ventas, Inc. (NYSE: VTR) will release its third quarter 2020 earnings on November 6, 2020, before the NYSE opens. The earnings call will take place that day at 10:00 a.m. ET. Investors can participate via a dial-in number or view the live webcast on the company's website. Ventas is a diversified real estate investment trust with approximately 1,200 properties across the U.S., Canada, and the U.K., focusing on senior housing and healthcare facilities. The company also offers management and advisory services through its Lillibridge subsidiary.
Ventas, Inc. (NYSE: VTR) announced the expiration and results of its cash offer to purchase all outstanding 3.25% Senior Notes due 2022, which concluded on September 29, 2020. A total of $236,268,000, or 47.25% of the notes, were validly tendered. The company plans to accept these notes for payment at $1,041.40 per $1,000 principal, with payment expected by October 2, 2020. Ventas, a diversified real estate investment trust, owns approximately 1,200 properties across the U.S., Canada, and the U.K., focused on senior housing and healthcare facilities.